by Admin | Sep 3, 2021 | CME INDIA Repository
CME INDIA Presentation by Admin. COV-BARRIER study is being cited as GREAT NEWS In spite of treatment advances with Remdesivir, Dexamethasone, and Tocilizumab, a crucial unmet need exists in reducing mortality among hospitalised COVID-19 patients. Baricitinib, a... 
by Admin | May 8, 2021 | CME INDIA Repository
CME INDIA Presentation by Admin. Among immunomodulators dexamethasone has made a relevant improvement on survival. But other immunomodulators are yet to show an impact. Recently few studies have shown the potential survival benefit of the JAK-STAT inhibitor...